Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report

被引：0
|
作者：
Caroline Y. Chen
Charlene M. Fares
Daniel Sanghoon Shin
机构：
[1] University of California Los Angeles,Department of Medicine, Division of Hematology/Oncology
[2] UCLA Medical Center,Department of Medicine, Division of Hematology/Oncology
[3] University of California Los Angeles,Division of Hematology/Oncology
[4] VA Greater Los Angeles Healthcare System,undefined
来源：
Journal of Medical Case Reports | / 15卷
关键词：
Non-small cell lung cancer; Tyrosine kinase inhibitors; Neoadjuvant; Case report;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report
    Chen, Caroline Y.
    Fares, Charlene M.
    Shin, Daniel Sanghoon
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [2] Radical resection in a patient with stage IIIA non-small cell lung cancer with the EGFR exon 19 deletion mutation after neoadjuvant targeted therapy with osimertinib: a case report
    Chen, Hao
    Zhang, Jiarong
    Osoegawa, Atsushi
    Calvetti, Lorenzo
    Fedele, Palma
    Chen, Chun
    Zheng, Bin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (06) : 1396 - 1406
  • [3] Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
    Hu, Yan
    Ren, Siying
    Yang, Lulu
    Tong, Zhongyi
    Wang, Ruoyao
    Han, Wei
    Zeng, Chao
    Li, Jina
    Xiao, Peng
    Wang, Li
    Yu, Fenglei
    Liu, Wenliang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [4] Stage IIIa Non-small Cell Lung Cancer: Surgical Timing after Neoadjuvant Therapy
    Lorenz, Judith
    PNEUMOLOGIE, 2020, 74 (12):
  • [5] Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy
    Broderick, Stephen R.
    Patel, Aalok P.
    Crabtree, Traves D.
    Bell, Jennifer M.
    Morgansztern, Daniel
    Robinson, Clifford G.
    Kreisel, Daniel
    Krupnick, A. Sasha
    Patterson, G. Alexander
    Meyers, Bryan F.
    Puri, Varun
    ANNALS OF THORACIC SURGERY, 2016, 101 (02): : 451 - 458
  • [6] Optimal Surgical Timing After Neoadjuvant Therapy for Stage IIIa Non-Small Cell Lung Cancer
    Rice, Jonathan D.
    Heidel, Justin
    Trivedi, Jaimin R.
    van Berkel, Victor H.
    ANNALS OF THORACIC SURGERY, 2020, 109 (03): : 842 - 847
  • [7] The Underrated Effect of Neoadjuvant Therapy Before Pneumonectomy for Stage IIIA Non-Small Cell Lung Cancer
    Riquet, Marc
    Arame, Alex
    Pricopi, Ciprian
    ANNALS OF THORACIC SURGERY, 2016, 102 (03): : 1030 - 1030
  • [8] Pathological complete response to neoadjuvant lorlatinib in a patient with stage IIIA ALK-positive non-small cell lung cancer: a case report
    Lu, Li
    Cao, Zhengqi
    Wang, Anni
    Chen, Lixuan
    Sun, Jing
    Li, Ziming
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (07) : 1742 - 1748
  • [9] Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Xu, Feng
    Hui, Zhenzhen
    Zhao, Gang
    Liu, Jie
    Zhang, Huan
    Zeng, Ziqing
    Zhang, Ran
    Provencio, Mariano
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2193 - +
  • [10] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03): : 949 - 958
12345